US Neuropathy Centers: Clinical Trials

3 trials sponsored by US Neuropathy Centers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 enrolling by invitation. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 2, Enrolling by invitation 1

Follow US Neuropathy Centers: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Can the Phoenix Sign be Elicited With D5W
Infiltration of D5W - Drop Foot
Not applicableEnrolling by invitationUS Neuropathy Centers6002026-04-102026-05-05
The Investigators Are Comparing Lidocaine and Papaverine Nerve Blocks to Determine Which Improves Blood Flow Better, Making the "Phoenix Sign" Clearer on Imaging. This Helps Accurately Diagnose Nerve Compression, Improving Patient Care
Infiltration of papaverine, Lidocaine infiltration - Drop Foot
Not applicableCompletedUS Neuropathy Centers42024-03-072025-04-09
Does Blood Vessel Vasodilation, Caused by Focal Infiltration of Lidocaine Cause Temporary Nerve Functional Recovery for Patients with Common Peroneal Nerve Injury or Entrapment: Testing the 'Phoenix Sign' Effect Between Lidocaine (a Common Local Anesthetic) and Papaverine, a Know Vasodilator
Diagnostic procedures, Lidocaine HCl - Drop Foot
Not applicableCompletedStephen Barrett202020-03-152024-10-15

Conditions studied

Peroneal Neuropathies (3)  ·  Nerve Compression Syndromes (1)

Interventions

Diagnostic Techniques and Procedures (1)

Countries

United States (3)

Top investigators

Stephen L Barrett, DPM MBA (1)

Results publications

PMID 39443927, PMID 42200998